Chemical formula: C₁₄H₁₁NO₅ Molecular mass: 273.241 g/mol PubChem compound: 4659569
Tolcapone is indicated for:
Population group: only adults (18 - 65 years old)
Tolcapone is indicated in combination with levodopa/benserazide or levodopa/carbidopa for use in patients with levodopa-responsive idiopathic Parkinson’s disease and motor fluctuations, who failed to respond to or are intolerant of other catechol-O-methyltransferase COMT inhibitors. Because of the risk of potentially fatal, acute liver injury, tolcapone should not be considered as a firstline adjunct therapy to levodopa/benserazide or levodopa/carbidopa.
Since tolcapone should be used only in combination with levodopa/benserazide and levodopa/carbidopa, the prescribing information for these levodopa preparations is also applicable to their concomitant use with tolcapone.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Tolcapone is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.